TMPRSS2 and COVID-19: Angiotensin-converting enzyme 2 (ACE2) and TMPRSS2 facilitate SARS-CoV-2 infection in cells, and the TMPRSS2 inhibitor has been proposed as a potential treatment for COVID-19.